Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rozman

Showing results (11-20 of 1,831) with videos related to

Pageof 184
Sort By:
Toxicology Letters|August 1, 1983
Relationship of body weight to disposition of hexachlorobenzene in ratsT Rozman, K Rozman, G S Smith
Sangre|December 1, 1990
[Antonio Raichs lecture. Graft versus host disease and the graft-against-leukemia reaction. Memorial lecture]C Rozman
Biochemical and Biophysical Research Communications|December 28, 1984
Hexadecane increases the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): is brown adipose tissue the primary target in TCDD-induced wasting syndrome?K Rozman
Revista Medica De Chile|December 1, 1976
[Current aspects of chronic lymphocytic leukemia (author's transl)]C Rozman
Haematologia|January 1, 1983
Bone marrow biopsyC Rozman
Journal of the American Society for Mass Spectrometry|October 4, 2005
The gas-phase H/D exchange mechanism of protonated amino acidsMarko Rozman
The Journal of Rheumatology. Supplement|July 17, 1998
Clinical experience with leflunomide in rheumatoid arthritis. Leflunomide Investigators' GroupB Rozman
Drug and Chemical Toxicology|January 1, 1981
Enhanced fecal excretion of mirex in rhesus monkeys by 5% mineral oil in the dietT Rozman, K Rozman, J Williams, et al.
Medicina Clinica|September 12, 1992
[Hyperthyroidism, another cause of hyperferritinemia]M Rozman, J L Vives Corrons, C Rozman
Clinical Pharmacokinetics|June 21, 2002
Clinical pharmacokinetics of leflunomideBlaz Rozman
Pageof 184

Showing results (11-20 of 1,831) with videos related to

Sort By:
Pageof 184
Toxicology Letters|August 1, 1983
Relationship of body weight to disposition of hexachlorobenzene in ratsT Rozman, K Rozman, G S Smith
Sangre|December 1, 1990
[Antonio Raichs lecture. Graft versus host disease and the graft-against-leukemia reaction. Memorial lecture]C Rozman
Biochemical and Biophysical Research Communications|December 28, 1984
Hexadecane increases the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): is brown adipose tissue the primary target in TCDD-induced wasting syndrome?K Rozman
Revista Medica De Chile|December 1, 1976
[Current aspects of chronic lymphocytic leukemia (author's transl)]C Rozman
Haematologia|January 1, 1983
Bone marrow biopsyC Rozman
Journal of the American Society for Mass Spectrometry|October 4, 2005
The gas-phase H/D exchange mechanism of protonated amino acidsMarko Rozman
The Journal of Rheumatology. Supplement|July 17, 1998
Clinical experience with leflunomide in rheumatoid arthritis. Leflunomide Investigators' GroupB Rozman
Drug and Chemical Toxicology|January 1, 1981
Enhanced fecal excretion of mirex in rhesus monkeys by 5% mineral oil in the dietT Rozman, K Rozman, J Williams, et al.
Medicina Clinica|September 12, 1992
[Hyperthyroidism, another cause of hyperferritinemia]M Rozman, J L Vives Corrons, C Rozman
Clinical Pharmacokinetics|June 21, 2002
Clinical pharmacokinetics of leflunomideBlaz Rozman
Pageof 184